Sleep & Wellness Guide

Emergent Biological Capabilities in a Foundation Model for Molecular Interactions

2026-11-10

Key Takeaway

A robotics research paper on Emergent Biological Capabilities in a Foundation Model for Molecular Interactions.

Practical Tips

Practical tips and how-to guidance will be added by our editorial team.

中文解读

中文解读待补充:本站将优先为睡眠改善、失眠治疗、助眠方法等高价值文章补充中文说明。

Article Summary

Foundation models trained on large unlabeled corpora develop emergent capabilities, tasks that go beyond the training objective. We extend this paradigm to multimodal biology with Bonbon, a foundation model for molecular interactions trained on approximately 3.2 trillion tokens of paired protein-ligand sequences. From a single representation space, Bonbon exhibits three zero-shot emergent capabilities at hierarchical levels of resolution: functional (mechanism of action), residue (binding site localization, including orthosteric/allosteric discrimination), and bond (covalent versus non-covalent engagement). All three capabilities generalize to out-of-distribution complexes. Bonbon was trained on protein-ligand sequences alone, without any task-specific supervision and without structural coordinates. We conducted controlled scaling experiments across six model scales from 42M to 1.6B parameters; every capability evaluated shows a sharp jump at the largest scale on continuous metrics, even as pretraining loss decreases smoothly. This demonstrates that loss-based scaling laws alone are insufficient to predict when zero-shot emergent capabilities become available. The capabilities reported here emerge after training at a 1:2,000 parameter-to-token ratio to accommodate the sparsity of paired biological interaction data. The same frozen representations achieve state-of-the-art binding and affinity prediction at five orders of magnitude greater speed than co-folding methods. In prospective wet-lab validation across nine disease targets spanning seven protein families, Bonbon achieves a 61.5% dose-response hit rate on de novo compounds, yielding structurally novel molecules not previously reported to inhibit these proteins, including for out-of-distribution targets.

5.0Practicality
7.0Scientific Evidence
4.0Effectiveness

Sources & References

Need to track a shipment?

Use our free logistics tracking tool to check real-time delivery status for USPS, FedEx, UPS, DHL, Amazon and 1000+ carriers worldwide.

Track a Package Now

Comments

No comments yet. Be the first to share your thoughts.
Login or register to leave a comment